Amylyx Pharmaceuticals, Inc. (AMLX)
33.94
+1.31
(+4.01%)
USD |
NASDAQ |
Sep 17, 16:00
33.66
-0.28
(-0.82%)
After-Hours: 07:06
Amylyx Pharmaceuticals 30-Day Average Daily Volume : 3.086M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.086M |
| September 16, 2026 | 3.092M |
| September 15, 2026 | 3.161M |
| September 14, 2026 | 3.156M |
| September 11, 2026 | 3.153M |
| September 10, 2026 | 3.214M |
| September 09, 2026 | 3.224M |
| September 08, 2026 | 3.295M |
| September 04, 2026 | 3.342M |
| September 03, 2026 | 3.367M |
| September 02, 2026 | 3.342M |
| September 01, 2026 | 3.329M |
| August 31, 2026 | 3.359M |
| August 28, 2026 | 3.316M |
| August 27, 2026 | 3.312M |
| August 26, 2026 | 3.277M |
| August 25, 2026 | 3.218M |
| August 24, 2026 | 3.213M |
| August 21, 2026 | 3.138M |
| August 20, 2026 | 3.019M |
| August 19, 2026 | 2.766M |
| August 18, 2026 | 2.521M |
| August 17, 2026 | 1.772M |
| August 14, 2026 | 1.776M |
| August 13, 2026 | 1.770M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.802M |
| August 11, 2026 | 1.849M |
| August 10, 2026 | 1.902M |
| August 07, 2026 | 1.976M |
| August 06, 2026 | 2.004M |
| August 05, 2026 | 1.937M |
| August 04, 2026 | 1.939M |
| August 03, 2026 | 1.871M |
| July 31, 2026 | 1.858M |
| July 30, 2026 | 1.833M |
| July 29, 2026 | 1.755M |
| July 28, 2026 | 1.783M |
| July 27, 2026 | 1.726M |
| July 24, 2026 | 1.709M |
| July 23, 2026 | 1.685M |
| July 22, 2026 | 1.691M |
| July 21, 2026 | 1.709M |
| July 20, 2026 | 1.676M |
| July 17, 2026 | 1.704M |
| July 16, 2026 | 1.696M |
| July 15, 2026 | 1.720M |
| July 14, 2026 | 1.708M |
| July 13, 2026 | 1.672M |
| July 10, 2026 | 1.642M |
| July 09, 2026 | 1.625M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Pfizer Inc. | 34.32M |
| Eli Lilly & Co. | 2.402M |
| Merck & Co., Inc. | 10.06M |
| EyePoint, Inc. | 5.840M |
| Bristol Myers Squibb Co. | 8.251M |